MONICA CASARIEGO: Open Payments
NPI 1326796046 · BERKELEY HEIGHTS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 43 payments from 13 companies in 2025. Trend: 2023 $963 · 2024 $1,016 · 2025 $912
Food & beverage: $813Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 5 | $190 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 11 | $186 |
| Incyte Corporation | 10 | $153 |
| Lilly USA, LLC | 2 | $124 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| ABBVIE INC. | 3 | $57 |
| Galderma Laboratories, L.P. | 2 | $33 |
| GENZYME CORPORATION | 1 | $22 |
| LEO Pharma Inc. | 1 | $18 |
| Organon LLC | 2 | $18 |
Products named: TREMFYA, OPZELURA, EBGLYSS, ILUMYA, Winlevi, RINVOQ, COSENTYX, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
